NFE2L2 and epilepsy: In conclusion, the results reported here suggest that oxidative processes may contribute to SE-induced neurodegeneration and clearly indicate that antioxidant treatment via Nrf2 activation using SFN can exert neuroprotection against SE-induced toxicity and has potential as a disease-modifying treatment in epilepsy.